Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 9/20 | 0.56 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.52 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.50 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.50 |
| ▸ | GRN | P28799 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levacetylleucine SCHEMBL9438432 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL714003 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Acetylleucine SCHEMBL282371 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL5527234 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL18954336 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL7923132 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL5532016 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Acetylleucine SCHEMBL25408262 | 0.94 | ALDH1A1 (0.88) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL6863674 | 0.92 | ALDH1A1 (0.85) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL17948650 | 0.92 | ALDH1A1 (0.85) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4186 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122055147-A | N-acetylleucine for the treatment of prodromal alpha-synucleinopathies | 内在生物技术股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260097008-A1 | ACETYL LEUCINE FOR USE IN TREATING NIEMANN-PICK DISEASE TYPE C | INTRABIO INC. | 2026-04-09 | — | — | US | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| US-20260027077-A1 | PHARMACEUTICAL COMPOSITIONS AND USES DIRECTED TO LYSOSOMAL STORAGE DISORDERS | INTRABIO LTD (US) | 2026-01-29 | — | — | US | claimed |
| US-12503719-B2 | Metabolomic characterization of microorganisms | LEWIS IAN ANDREW (CA) | 2025-12-23 | — | — | US | claimed |
| US-20250353832-A1 | PROCESS FOR THE PREPARATION OF AMINOPYRIDAZINE DERIVATIVES | ADAMA MAKHTESHIM LTD. (IL) | 2025-11-20 | — | — | US | claimed |
| EP-4650003-A2 | COMBINATION THERAPY WITH ACETYL-LEUCINE AND MIGLUSTAT FOR TREATING A LYSOSOMAL STORAGE DISEASE | IntraBio Ltd (GB) | 2025-11-19 | — | — | EP | claimed |
| US-12458614-B2 | Therapeutic agents for improved mobility and cognitive function and for treating neurodegenerative diseases and lysosomal storage disorders | INTRABIO LTD (GB) | 2025-11-04 | — | — | US | claimed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | claimed |
| US-5206162-A | Process for making D-aminoacylase | NATIONAL SCIENCE COUNCIL OF REPUBLIC OF CHINA (TW) | 1993-04-27 | — | — | US | claimed |
| US-5194383-A | Culturing alcaligenes denitrificans, separation, purification | NATIONAL SCIENCE COUNCIL OF REPUBLIC OF CHINA (TW) | 1993-03-16 | — | — | US | claimed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | claimed |
| EP-0452000-A2 | Preparation of optically active norbornyl amine derivatives | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1991-10-16 | — | — | EP | claimed |
| EP-0381997-A1 | Microbially prepared N-acetyl-2,3-didehydroleucine acylase, process for its preparation and its use | Degussa Aktiengesellschaft (DE) | 1990-08-16 | — | — | EP | claimed |
| EP-0126886-B1 | PROCESS FOR THE SEPARATION OF L-LEUCINE AND L-ISOLEUCINE | Degussa Aktiengesellschaft (DE) | 1986-06-11 | — | — | EP | claimed |
| EP-0126887-B1 | PROCESS FOR OBTAINING PURE L-LEUCINE | Degussa Aktiengesellschaft (DE) | 1986-06-04 | — | — | EP | claimed |
| US-4562153-A | Process for the separation of L-leucine and L-isoleucine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1985-12-31 | — | — | US | claimed |
| US-4401827-A | CARDIOTONIC AND ANTILIPEMIC AGENTS; BLOOD DISORDERS | SIGMA-TAU (IT) | 1983-08-30 | — | — | US | claimed |